Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease

Saved in:
Bibliographic Details
Main Authors: Krishnagopal Srikanth, V Sridhanya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Indian Journal of Ophthalmology
Online Access:https://journals.lww.com/10.4103/IJO.IJO_2424_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556830367514624
author Krishnagopal Srikanth
V Sridhanya
author_facet Krishnagopal Srikanth
V Sridhanya
author_sort Krishnagopal Srikanth
collection DOAJ
format Article
id doaj-art-eb579125b8ae4591894e901208aab21b
institution Kabale University
issn 0301-4738
1998-3689
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj-art-eb579125b8ae4591894e901208aab21b2025-01-07T06:27:43ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892025-01-0173115415410.4103/IJO.IJO_2424_24Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye diseaseKrishnagopal SrikanthV Sridhanyahttps://journals.lww.com/10.4103/IJO.IJO_2424_24
spellingShingle Krishnagopal Srikanth
V Sridhanya
Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
Indian Journal of Ophthalmology
title Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
title_full Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
title_fullStr Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
title_full_unstemmed Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
title_short Comment on efficacy, safety, and tolerability of Lifitegrast 5% eye drops: A randomized, double-blind, active-controlled trial in Indian patients with dry eye disease
title_sort comment on efficacy safety and tolerability of lifitegrast 5 eye drops a randomized double blind active controlled trial in indian patients with dry eye disease
url https://journals.lww.com/10.4103/IJO.IJO_2424_24
work_keys_str_mv AT krishnagopalsrikanth commentonefficacysafetyandtolerabilityoflifitegrast5eyedropsarandomizeddoubleblindactivecontrolledtrialinindianpatientswithdryeyedisease
AT vsridhanya commentonefficacysafetyandtolerabilityoflifitegrast5eyedropsarandomizeddoubleblindactivecontrolledtrialinindianpatientswithdryeyedisease